List of insiders holdings for Forte Biosciences Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
1 | GRUBER HARRY E President, Science&Innovation | 2020-02-28 16:32:16 | 23,685 417,753 | 441,438 | Form 4 |
2 | Oliveira Steven Michael 10% Owner | 2025-01-10 20:13:21 | 432,276 0 | 432,276 | Form 13G |
3 | Chen Hubert C See remarks | 2024-01-03 16:04:40 | 183,405 0 | 183,405 | Form 4 |
4 | Wagner Paul A. SEE REMARKS | 2025-04-02 17:01:48 | 88,538 0 | 88,538 | Form 4 |
5 | Das Asha SVP & Chief Medical Officer | 2018-03-02 17:13:25 | 70,000 0 | 70,000 | Form 4 |
6 | Eichenfield Lawrence Director | 2024-08-22 16:12:00 | 50,000 0 | 50,000 | Form 4 |
7 | Williams Donald Allen Director | 2024-08-22 16:07:40 | 50,000 0 | 50,000 | Form 4 |
8 | Duvall Martin J Chief Executive Officer | 2019-10-04 20:34:10 | 50,000 0 | 50,000 | Form 4 |
9 | Riley Antony A CHIEF FINANCIAL OFFICER | 2025-04-02 17:03:05 | 33,843 0 | 33,843 | Form 4 |
10 | GRYSKA DAVID W Director | 2025-03-21 16:51:12 | 31,000 0 | 31,000 | Form 4 |
11 | VINCENT RICHARD G Director | 2025-03-21 16:50:05 | 31,000 0 | 31,000 | Form 4 |
12 | Kapoor Shivpreet Singh Director | 2025-03-21 16:48:56 | 31,000 0 | 31,000 | Form 4 |
13 | Doberstein Stephen K Director | 2025-03-21 16:48:01 | 31,000 0 | 31,000 | Form 4 |
14 | FINCK BARBARA K Director | 2025-03-21 16:37:43 | 31,000 0 | 31,000 | Form 4 |
15 | Kornfeld Steven Director | 2025-03-21 16:45:08 | 31,000 0 | 31,000 | Form 4 |
16 | Brun Scott C. Director | 2025-03-21 16:46:35 | 31,000 0 | 31,000 | Form 4 |
17 | FOLETTA MARK G EVP & Chief Financial Officer | 2019-10-04 20:38:01 | 30,000 0 | 30,000 | Form 4 |
18 | DARCY THOMAS E Director | 2021-01-14 19:17:31 | 2,358 24,637 | 26,995 | Form 4 |
19 | Walker Patricia S Director | 2022-06-02 17:13:27 | 25,000 0 | 25,000 | Form 4 |
20 | Kabbinavar Fairooz SVP Clinical Development | 2019-10-04 20:36:06 | 20,000 0 | 20,000 | Form 4 |
21 | Jolly Douglas EVP, Research & Pharm Devel | 2019-10-04 20:40:19 | 12,500 0 | 12,500 | Form 4 |
22 | Parkinson David Ross Director | 2019-10-04 20:14:03 | 7,500 0 | 7,500 | Form 4 |
23 | Hasnain Faheem Director | 2019-10-04 20:22:03 | 7,500 0 | 7,500 | Form 4 |
24 | BERGER FRANKLIN M Director | 2019-10-04 20:29:49 | 7,500 0 | 7,500 | Form 4 |
25 | Kunkel Lori Anne Director | 2019-10-04 20:31:31 | 7,500 0 | 7,500 | Form 4 |
26 | SCHIMMEL PAUL Director | 2019-10-04 20:11:39 | 7,500 0 | 7,500 | Form 4 |
27 | BERMAN DENNIS N former director & officer Director | 2017-04-17 18:23:38 | 0 0 | 0 | Form 4 |